Iron Horse Wealth Management’s GSK GSK Stock Holding History

Iron Horse Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,000	Closed	-$33.8K	–	626
2024 Q4	$33.8K	Buy	1,000 +200	+25%	+$7.2K	0.01%	146
2024 Q3	$32.7K	Sell	800 -200	-20%	-$8.18K	0.01%	138
2024 Q2	$38.5K	Hold	1,000	–	–	0.01%	120
2024 Q1	$42.9K	Hold	1,000	–	–	0.02%	96
2023 Q4	$37.1K	Hold	1,000	–	–	0.02%	89
2023 Q3	$36.3K	Hold	1,000	–	–	0.02%	88
2023 Q2	$35.6K	Buy	1,000 +100	+11%	+$3.59K	0.02%	85
2023 Q1	$32K	Hold	900	–	–	0.02%	88
2022 Q4	$32K	Buy	900 +100	+13%	+$3.33K	0.02%	87
2022 Q3	$24K	Buy	+800	New	+$30.3K	0.03%	56
2021 Q4	–	Sell	-52	Closed	-$2K	–	224
2021 Q3	$2K	Hold	52	–	–	﹤0.01%	155
2021 Q2	$3K	Hold	52	–	–	﹤0.01%	148
2021 Q1	$2K	Buy	+52	New	+$2.36K	﹤0.01%	147

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Iron Horse Wealth Management's GSK Position: Q1 2025 in Review

Iron Horse Wealth Management sold out of GSK (GSK) in Q1 2025, closing a stake of 1,000 shares — an estimated $33.8K sold.

Iron Horse Wealth Management first reported a position in GSK in Q1 2021 and held it in 13 quarters. The position peaked at $42.9K in Q1 2024. 857 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

Iron Horse Wealth Management reported no remaining GSK position as of Q1 2025 after selling out during the quarter.
Iron Horse Wealth Management sold 1,000 GSK shares in Q1 2025, an estimated $33.8K.
Iron Horse Wealth Management first reported a position in GSK in Q1 2021 and held it in 13 quarters.
Iron Horse Wealth Management's GSK position peaked at $42.9K in Q1 2024.
857 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Iron Horse Wealth Management's 13F filing for Q1 2025, filed 1 May 2025.